Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection - Concepedia

Concepedia

Publication | Open Access

Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection

DOI Full Paper Access

96

Citations

52

References

2022

Year

Jan Van Elslande, Matthijs Oyaert, Natalie Lorent, Yannick Vande Weygaerde, Gijs Van Pottelbergh, Lode Godderis, Marc Van Ranst, Emmanuel André, Elizaveta Padalko, Katrien Lagrou,

Diagnostic Microbiology and Infectious Disease

VaccinationViral PersistenceSars-cov-2 InfectionImmunologyViral PathogenesisVirologyLower PersistenceChronic Viral InfectionAnti-spike AntibodiesViral Structural ProteinMedicineCovid-19

References

	Year	Citations

Page 1

Page 1